Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $167B
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Quarter Return
+10.14%
1 Year Return
+24.69%
3 Year Return
+110.21%
5 Year Return
+190.84%
10 Year Return
+479.95%
AUM
$147B
AUM Growth
+$147B
Cap. Flow
-$10.5B
Cap. Flow %
-7.11%
Top 10 Hldgs %
27.87%
Holding
2,706
New
63
Increased
1,304
Reduced
972
Closed
106

Sector Composition

1 Technology 30.21%
2 Healthcare 13.75%
3 Consumer Discretionary 12.04%
4 Industrials 9.23%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ACB
2601
Aurora Cannabis
ACB
$305M
-654,272 Closed -$454K
BRMK
2602
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
-286,900 Closed -$1.35M
GEVO icon
2603
Gevo
GEVO
$418M
-512,000 Closed -$788K
GILT icon
2604
Gilat Satellite Networks
GILT
$538M
-92,328 Closed -$466K
GPMT
2605
Granite Point Mortgage Trust
GPMT
$137M
-112,977 Closed -$560K
GTE icon
2606
Gran Tierra Energy
GTE
$145M
-796,300 Closed -$700K
GWH icon
2607
ESS Tech
GWH
$20.8M
-124,700 Closed -$173K
HLLY icon
2608
Holley
HLLY
$490M
-102,100 Closed -$280K
KOD icon
2609
Kodiak Sciences
KOD
$478M
-73,400 Closed -$455K
KZR icon
2610
Kezar Life Sciences
KZR
$28.9M
-110,700 Closed -$346K
NKTR icon
2611
Nektar Therapeutics
NKTR
$568M
-405,700 Closed -$285K
NRGV icon
2612
Energy Vault
NRGV
$327M
-149,186 Closed -$319K
OGI
2613
Organigram Holdings
OGI
$232M
-581,000 Closed -$369K
ORGO icon
2614
Organogenesis Holdings
ORGO
$653M
-127,100 Closed -$271K
FULC icon
2615
Fulcrum Therapeutics
FULC
$351M
-86,500 Closed -$247K
ACET icon
2616
Adicet Bio
ACET
$59.9M
-41,600 Closed -$240K
ADV icon
2617
Advantage Solutions
ADV
$593M
-172,500 Closed -$273K
AEVA
2618
Aeva Technologies
AEVA
$834M
-235,600 Closed -$280K
ALT icon
2619
Altimmune
ALT
$338M
-106,100 Closed -$448K
ALXO icon
2620
ALX Oncology
ALXO
$62.7M
-39,500 Closed -$179K
AMRX icon
2621
Amneal Pharmaceuticals
AMRX
$3B
-212,500 Closed -$295K
ATRA icon
2622
Atara Biotherapeutics
ATRA
$84.6M
-174,000 Closed -$505K
AUDC icon
2623
AudioCodes
AUDC
$273M
-54,561 Closed -$799K
AVIR icon
2624
Atea Pharmaceuticals
AVIR
$267M
-161,800 Closed -$542K
BIRD icon
2625
Allbirds
BIRD
$52.4M
-207,700 Closed -$249K